M&A Deal Summary |
|
---|---|
Date | 2003-02-18 |
Target | Jomed N.V. - Heart Valve Repair Program |
Sector | Medical Products |
Buyer(s) | Edwards |
Sellers(s) | Jomed N.V. |
Deal Type | Divestiture |
Deal Value | 20M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1958 |
Sector | Medical Products |
Employees | 19,800 |
Revenue | 6.0B USD (2023) |
Edwards is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. Edwards was founded in 1958 and is based in Irvine, California.
DEAL STATS | # |
---|---|
Overall | 2 of 15 |
Sector (Medical Products) | 2 of 12 |
Type (Divestiture) | 2 of 5 |
Country (Netherlands) | 1 of 2 |
Year (2003) | 1 of 3 |
Size (of disclosed) | 9 of 10 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2002-10-01 |
Baxter International - Cardiovascular Businesss
Japan Baxter International, Inc. - Cardiovascular Businesss is a manufacturer of medical products for cardio. |
Buy | $22M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2003-05-01 |
Embol-X
Mountain View, California, United States Embol-X, Inc. is a provider of technology designed to capture emboli, such as blood clots or tissue fragments, thus preventing them from traveling through a patient's bloodstream during cardiac surgery. |
Buy | - |
Jomed N.V. develops, produces, sells, and distributes cardiovascular devices.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
Country (Netherlands) | 1 of 1 |
Year (2003) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2000-09-04 |
EndoSonics
Rancho Cordova, California, United States EndoSonics Corp. engages in the development of devices for the diagnosis and treatment of cardiovascular disease. |
Buy | - |